Index by author

01 November 2002; volume 20, issue 5

A

  1. Alchanatis, M.

    1. Alchanatis, M. et al "Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome." European Respiratory Journal 20.5 (2002): 1239-1245. Web. 23 June. 2021.

  2. Amicosante, M.

    1. Amicosante, M. et al "HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells." European Respiratory Journal 20.5 (2002): 1174-1178. Web. 23 June. 2021.

  3. Ángeles Marcos, M.

    1. Ewig, S. et al "Factors associated with unknown aetiology in patients with community-acquired pneumonia." European Respiratory Journal 20.5 (2002): 1254-1262. Web. 23 June. 2021.

  4. Angrill, J.

    1. Ewig, S. et al "Factors associated with unknown aetiology in patients with community-acquired pneumonia." European Respiratory Journal 20.5 (2002): 1254-1262. Web. 23 June. 2021.

  5. Aritomi, T.

    1. Watanabe, K. et al "Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia." European Respiratory Journal 20.5 (2002): 1213-1219. Web. 23 June. 2021.

  6. Arweström, E.

    1. Wadbo, M. et al "Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study." European Respiratory Journal 20.5 (2002): 1138-1146. Web. 23 June. 2021.

  7. Assimakopoulos, T.

    1. Dingli, K. et al "Electroencephalographic spectral analysis: detection of cortical activity changes in sleep apnoea patients." European Respiratory Journal 20.5 (2002): 1246-1253. Web. 23 June. 2021.

B

  1. Bakke, P.S.

    1. Hardie, J.A. et al "Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers." European Respiratory Journal 20.5 (2002): 1117-1122. Web. 23 June. 2021.

  2. Bauer, T.

    1. Ewig, S. et al "Factors associated with unknown aetiology in patients with community-acquired pneumonia." European Respiratory Journal 20.5 (2002): 1254-1262. Web. 23 June. 2021.

  3. Behr, J.

    1. Behr, J.. "Is “nonusual interstitial pneumonia” an acceptable diagnosis?." European Respiratory Journal 20.5 (2002): 1069-1070. Web. 23 June. 2021.

  4. Bengtsson, T.

    1. Wadbo, M. et al "Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study." European Respiratory Journal 20.5 (2002): 1138-1146. Web. 23 June. 2021.

  5. Bensch, G.

    1. Buhl, R. et al "The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma." European Respiratory Journal 20.5 (2002): 1088-1094. Web. 23 June. 2021.

  6. Bernard, A.

    1. Robin, M. et al "Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects." European Respiratory Journal 20.5 (2002): 1152-1161. Web. 23 June. 2021.

  7. Berretta, F.

    1. Amicosante, M. et al "HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells." European Respiratory Journal 20.5 (2002): 1174-1178. Web. 23 June. 2021.

  8. Bersten, A.D.

    1. Robin, M. et al "Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects." European Respiratory Journal 20.5 (2002): 1152-1161. Web. 23 June. 2021.

  9. Billon-Galland, M.A.

    1. Paris, C. et al "Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure." European Respiratory Journal 20.5 (2002): 1167-1173. Web. 23 June. 2021.

  10. Bittscheidt, J.

    1. Schauer, U. et al "RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life." European Respiratory Journal 20.5 (2002): 1277-1283. Web. 23 June. 2021.

  11. Bongartz, S.

    1. Schauer, U. et al "RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life." European Respiratory Journal 20.5 (2002): 1277-1283. Web. 23 June. 2021.

  12. Boulé, M.

    1. Nève, V. et al "Lung and thorax development during adolescence: relationship with pubertal status." European Respiratory Journal 20.5 (2002): 1292-1298. Web. 23 June. 2021.

  13. Brimioulle, S.

    1. Chemla, D. et al "Haemodynamic evaluation of pulmonary hypertension." European Respiratory Journal 20.5 (2002): 1314-1331. Web. 23 June. 2021.

  14. Brunekreef, B.

    1. Brunekreef, B.. "Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren." European Respiratory Journal 20.5 (2002): 1354-1355. Web. 23 June. 2021.

  15. Buhl, R.

    1. Buhl, R. et al "The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma." European Respiratory Journal 20.5 (2002): 1088-1094. Web. 23 June. 2021.

  16. Buist, A.S.

    1. Hardie, J.A. et al "Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers." European Respiratory Journal 20.5 (2002): 1117-1122. Web. 23 June. 2021.

  17. Burgel, P-R.

    1. Kohri, K. et al "Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor." European Respiratory Journal 20.5 (2002): 1263-1270. Web. 23 June. 2021.

C

  1. Cabello-Rueda, F.

    1. Ignacio-García, J-M. et al "Benefits at 3 yrs of an asthma education programme coupled with regular reinforcement." European Respiratory Journal 20.5 (2002): 1095-1101. Web. 23 June. 2021.

  2. Castelain, V.

    1. Chemla, D. et al "Haemodynamic evaluation of pulmonary hypertension." European Respiratory Journal 20.5 (2002): 1314-1331. Web. 23 June. 2021.

  3. Cayton, R.M.

    1. Chakravorty, I., R.M. Cayton, and A. Szczepura. "Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome." European Respiratory Journal 20.5 (2002): 1233-1238. Web. 23 June. 2021.

  4. Chakravorty, I.

    1. Chakravorty, I., R.M. Cayton, and A. Szczepura. "Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome." European Respiratory Journal 20.5 (2002): 1233-1238. Web. 23 June. 2021.

  5. Champain, K.

    1. Buhl, R. et al "The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma." European Respiratory Journal 20.5 (2002): 1088-1094. Web. 23 June. 2021.

  6. Chemla, D.

    1. Chemla, D. et al "Haemodynamic evaluation of pulmonary hypertension." European Respiratory Journal 20.5 (2002): 1314-1331. Web. 23 June. 2021.

  7. Chen, Y.

    1. Chen, Y. et al "Sex-related interactive effect of smoking and household pets on asthma incidence." European Respiratory Journal 20.5 (2002): 1162-1166. Web. 23 June. 2021.

  8. Chevreau, L.

    1. Paris, C. et al "Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure." European Respiratory Journal 20.5 (2002): 1167-1173. Web. 23 June. 2021.

  9. Chocrón-Giraldez, M.J.

    1. Ignacio-García, J-M. et al "Benefits at 3 yrs of an asthma education programme coupled with regular reinforcement." European Respiratory Journal 20.5 (2002): 1095-1101. Web. 23 June. 2021.

  10. Couillard, A.

    1. Couillard, A. et al "Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients." European Respiratory Journal 20.5 (2002): 1123-1129. Web. 23 June. 2021.

  11. Creveuil, C.

    1. Paris, C. et al "Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure." European Respiratory Journal 20.5 (2002): 1167-1173. Web. 23 June. 2021.

  12. Cristol, J.P.

    1. Couillard, A. et al "Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients." European Respiratory Journal 20.5 (2002): 1123-1129. Web. 23 June. 2021.

D

  1. Dales, R.

    1. Chen, Y. et al "Sex-related interactive effect of smoking and household pets on asthma incidence." European Respiratory Journal 20.5 (2002): 1162-1166. Web. 23 June. 2021.

  2. Dao-Pick, T.

    1. Kohri, K. et al "Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor." European Respiratory Journal 20.5 (2002): 1263-1270. Web. 23 June. 2021.

  3. de Blay, F.

    1. Olgart Höglund, C. et al "Nerve growth factor levels and localisation in human asthmatic bronchi." European Respiratory Journal 20.5 (2002): 1110-1116. Web. 23 June. 2021.

  4. de Blic, J.

    1. de Blic, J., V. Marchac, and P. Scheinmann. "Complications of flexible bronchoscopy in children: prospective study of 1,328 procedures." European Respiratory Journal 20.5 (2002): 1271-1276. Web. 23 June. 2021.

  5. de la Bellacasa, J.P.

    1. Ewig, S. et al "Factors associated with unknown aetiology in patients with community-acquired pneumonia." European Respiratory Journal 20.5 (2002): 1254-1262. Web. 23 June. 2021.

  6. de Ramón-Garrido, E.

    1. Ignacio-García, J-M. et al "Benefits at 3 yrs of an asthma education programme coupled with regular reinforcement." European Respiratory Journal 20.5 (2002): 1095-1101. Web. 23 June. 2021.

  7. de Roux, A.

    1. Ewig, S. et al "Factors associated with unknown aetiology in patients with community-acquired pneumonia." European Respiratory Journal 20.5 (2002): 1254-1262. Web. 23 June. 2021.

  8. Dingli, K.

    1. Dingli, K. et al "Electroencephalographic spectral analysis: detection of cortical activity changes in sleep apnoea patients." European Respiratory Journal 20.5 (2002): 1246-1253. Web. 23 June. 2021.

  9. Dong, P.

    1. Robin, M. et al "Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects." European Respiratory Journal 20.5 (2002): 1152-1161. Web. 23 June. 2021.

  10. Dotti, C.

    1. Amicosante, M. et al "HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells." European Respiratory Journal 20.5 (2002): 1174-1178. Web. 23 June. 2021.

  11. Douglas, N.J.

    1. Dingli, K. et al "Electroencephalographic spectral analysis: detection of cortical activity changes in sleep apnoea patients." European Respiratory Journal 20.5 (2002): 1246-1253. Web. 23 June. 2021.

  12. Doyle, I.R.

    1. Robin, M. et al "Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects." European Respiratory Journal 20.5 (2002): 1152-1161. Web. 23 June. 2021.

  13. du Bois, R.M.

    1. Pantelidis, P. et al "Single-cell analysis: a novel approach to tumour necrosis factor-α synthesis and secretion in sarcoidosis." European Respiratory Journal 20.5 (2002): 1179-1184. Web. 23 June. 2021.
    2. Petrek, M. et al "CC and C chemokine expression in pulmonary sarcoidosis." European Respiratory Journal 20.5 (2002): 1206-1212. Web. 23 June. 2021.

  14. Duvernelle, C.

    1. Olgart Höglund, C. et al "Nerve growth factor levels and localisation in human asthmatic bronchi." European Respiratory Journal 20.5 (2002): 1110-1116. Web. 23 June. 2021.

  15. Dweik, R.

    1. Amicosante, M. et al "HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells." European Respiratory Journal 20.5 (2002): 1174-1178. Web. 23 June. 2021.

E

  1. Egan, J.J.

    1. Lok, S.S. et al "Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice." European Respiratory Journal 20.5 (2002): 1228-1232. Web. 23 June. 2021.

  2. Ellingsen, I.

    1. Hardie, J.A. et al "Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers." European Respiratory Journal 20.5 (2002): 1117-1122. Web. 23 June. 2021.

  3. Everhard, F.

    1. Buhl, R. et al "The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma." European Respiratory Journal 20.5 (2002): 1088-1094. Web. 23 June. 2021.

  4. Ewig, S.

    1. Ewig, S. et al "Factors associated with unknown aetiology in patients with community-acquired pneumonia." European Respiratory Journal 20.5 (2002): 1254-1262. Web. 23 June. 2021.

F

  1. Fehrenbach, A.

    1. Fehrenbach, H. et al "Keratinocyte growth factor-induced proliferation of rat airway epithelium is restricted to Clara cells in vivo." European Respiratory Journal 20.5 (2002): 1185-1197. Web. 23 June. 2021.

  2. Fehrenbach, H.

    1. Fehrenbach, H. et al "Keratinocyte growth factor-induced proliferation of rat airway epithelium is restricted to Clara cells in vivo." European Respiratory Journal 20.5 (2002): 1185-1197. Web. 23 June. 2021.

  3. Fietze, I.

    1. Dingli, K. et al "Electroencephalographic spectral analysis: detection of cortical activity changes in sleep apnoea patients." European Respiratory Journal 20.5 (2002): 1246-1253. Web. 23 June. 2021.

  4. FitzGerald, M.X.

    1. Henry, M.T. et al "Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF." European Respiratory Journal 20.5 (2002): 1220-1227. Web. 23 June. 2021.

  5. Flahault, A.

    1. Nève, V. et al "Lung and thorax development during adolescence: relationship with pubertal status." European Respiratory Journal 20.5 (2002): 1292-1298. Web. 23 June. 2021.

  6. Folgering, H.T.M.

    1. Wagenaar, M. et al "Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients." European Respiratory Journal 20.5 (2002): 1130-1137. Web. 23 June. 2021.

  7. Fox, H.

    1. Buhl, R. et al "The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma." European Respiratory Journal 20.5 (2002): 1088-1094. Web. 23 June. 2021.

  8. Franchi, A.

    1. Amicosante, M. et al "HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells." European Respiratory Journal 20.5 (2002): 1174-1178. Web. 23 June. 2021.

  9. Frischer, T.

    1. Horak, F. et al "From the Authors." European Respiratory Journal 20.5 (2002): 1355. Web. 23 June. 2021.

  10. Frossard, N.

    1. Olgart Höglund, C. et al "Nerve growth factor levels and localisation in human asthmatic bronchi." European Respiratory Journal 20.5 (2002): 1110-1116. Web. 23 June. 2021.

  11. Fujiuchi, S.

    1. Yamamoto, Y. et al "Extrinsic allergic alveolitis induced by the yeast Debaryomyces Hansenii." European Respiratory Journal 20.5 (2002): 1351-1353. Web. 23 June. 2021.

G

  1. Gaga, M.

    1. Alchanatis, M. et al "Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome." European Respiratory Journal 20.5 (2002): 1239-1245. Web. 23 June. 2021.

  2. Galateau-Salle, F.

    1. Paris, C. et al "Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure." European Respiratory Journal 20.5 (2002): 1167-1173. Web. 23 June. 2021.

  3. Gartner, C.

    1. Horak, F. et al "From the Authors." European Respiratory Journal 20.5 (2002): 1355. Web. 23 June. 2021.

  4. Gillon, J.C.

    1. Paris, C. et al "Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure." European Respiratory Journal 20.5 (2002): 1167-1173. Web. 23 June. 2021.

  5. Girard, F.

    1. Nève, V. et al "Lung and thorax development during adolescence: relationship with pubertal status." European Respiratory Journal 20.5 (2002): 1292-1298. Web. 23 June. 2021.

  6. Griese, M.

    1. Griese, M. et al "Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates." European Respiratory Journal 20.5 (2002): 1284-1291. Web. 23 June. 2021.

H

  1. Haider, Y.

    1. Lok, S.S. et al "Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice." European Respiratory Journal 20.5 (2002): 1228-1232. Web. 23 June. 2021.

  2. Hajiro, T.

    1. Oga, T. et al "Health status measured with the CRQ does not predict mortality in COPD." European Respiratory Journal 20.5 (2002): 1147-1151. Web. 23 June. 2021.

  3. Hanf, G.

    1. Buhl, R. et al "The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma." European Respiratory Journal 20.5 (2002): 1088-1094. Web. 23 June. 2021.

  4. Hardie, J.A.

    1. Hardie, J.A. et al "Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers." European Respiratory Journal 20.5 (2002): 1117-1122. Web. 23 June. 2021.

  5. Hasleton, P.S.

    1. Lok, S.S. et al "Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice." European Respiratory Journal 20.5 (2002): 1228-1232. Web. 23 June. 2021.

  6. Heijdra, Y.F.

    1. Wagenaar, M. et al "Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients." European Respiratory Journal 20.5 (2002): 1130-1137. Web. 23 June. 2021.

  7. Hemmis, S.

    1. Schauer, U. et al "RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life." European Respiratory Journal 20.5 (2002): 1277-1283. Web. 23 June. 2021.

  8. Henry, M.T.

    1. Henry, M.T. et al "Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF." European Respiratory Journal 20.5 (2002): 1220-1227. Web. 23 June. 2021.

  9. Hermans, C.

    1. Robin, M. et al "Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects." European Respiratory Journal 20.5 (2002): 1152-1161. Web. 23 June. 2021.

  10. Hervé, P.

    1. Chemla, D. et al "Haemodynamic evaluation of pulmonary hypertension." European Respiratory Journal 20.5 (2002): 1314-1331. Web. 23 June. 2021.

  11. Higuchi, K.

    1. Watanabe, K. et al "Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia." European Respiratory Journal 20.5 (2002): 1213-1219. Web. 23 June. 2021.

  12. Hoffjan, S.

    1. Schauer, U. et al "RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life." European Respiratory Journal 20.5 (2002): 1277-1283. Web. 23 June. 2021.

  13. Holgate, S.T.

    1. Zhang, J. et al "Variability and lack of predictive ability of asthma end-points in clinical trials." European Respiratory Journal 20.5 (2002): 1102-1109. Web. 23 June. 2021.

  14. Horak, F.

    1. Horak, F. et al "From the Authors." European Respiratory Journal 20.5 (2002): 1355. Web. 23 June. 2021.

  15. Howell, D.

    1. Lok, S.S. et al "Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice." European Respiratory Journal 20.5 (2002): 1228-1232. Web. 23 June. 2021.

I

  1. Ignacio-García, J-M.

    1. Ignacio-García, J-M. et al "Benefits at 3 yrs of an asthma education programme coupled with regular reinforcement." European Respiratory Journal 20.5 (2002): 1095-1101. Web. 23 June. 2021.
    2. Ignacio-García, J-M. et al "Benefits at 3 yrs of an asthma education programme coupled with regular reinforcement." European Respiratory Journal 20.5 (2002): 1095-1101. Web. 23 June. 2021.

  2. Ikeda, A.

    1. Oga, T. et al "Health status measured with the CRQ does not predict mortality in COPD." European Respiratory Journal 20.5 (2002): 1147-1151. Web. 23 June. 2021.

J

  1. Janicki, S.

    1. Kanniess, F. et al "Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma." European Respiratory Journal 20.5 (2002): 1080-1087. Web. 23 June. 2021.

  2. Je Vos, P.

    1. Wagenaar, M. et al "Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients." European Respiratory Journal 20.5 (2002): 1130-1137. Web. 23 June. 2021.

  3. Jordanoglou, J.B.

    1. Alchanatis, M. et al "Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome." European Respiratory Journal 20.5 (2002): 1239-1245. Web. 23 June. 2021.

  4. Jörres, R.A.

    1. Kanniess, F. et al "Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma." European Respiratory Journal 20.5 (2002): 1080-1087. Web. 23 June. 2021.

K

  1. Kakouros, S.

    1. Alchanatis, M. et al "Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome." European Respiratory Journal 20.5 (2002): 1239-1245. Web. 23 June. 2021.

  2. Kanniess, F.

    1. Kanniess, F. et al "Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma." European Respiratory Journal 20.5 (2002): 1080-1087. Web. 23 June. 2021.

  3. Kasper, M.

    1. Fehrenbach, H. et al "Keratinocyte growth factor-induced proliferation of rat airway epithelium is restricted to Clara cells in vivo." European Respiratory Journal 20.5 (2002): 1185-1197. Web. 23 June. 2021.

  4. Kassel, O.

    1. Olgart Höglund, C. et al "Nerve growth factor levels and localisation in human asthmatic bronchi." European Respiratory Journal 20.5 (2002): 1110-1116. Web. 23 June. 2021.

  5. Kawabata, Y.

    1. Watanabe, K. et al "Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia." European Respiratory Journal 20.5 (2002): 1213-1219. Web. 23 June. 2021.

  6. Kikuchi, K.

    1. Yamamoto, Y. et al "Extrinsic allergic alveolitis induced by the yeast Debaryomyces Hansenii." European Respiratory Journal 20.5 (2002): 1351-1353. Web. 23 June. 2021.

  7. Köchling, A.

    1. Schauer, U. et al "RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life." European Respiratory Journal 20.5 (2002): 1277-1283. Web. 23 June. 2021.

  8. Koechlin, C.

    1. Couillard, A. et al "Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients." European Respiratory Journal 20.5 (2002): 1123-1129. Web. 23 June. 2021.

  9. Kohri, K.

    1. Kohri, K. et al "Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor." European Respiratory Journal 20.5 (2002): 1263-1270. Web. 23 June. 2021.

  10. Kolek, V.

    1. Petrek, M. et al "CC and C chemokine expression in pulmonary sarcoidosis." European Respiratory Journal 20.5 (2002): 1206-1212. Web. 23 June. 2021.

  11. Kosmas, E.N.

    1. Alchanatis, M. et al "Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome." European Respiratory Journal 20.5 (2002): 1239-1245. Web. 23 June. 2021.

  12. Krewski, D.

    1. Chen, Y. et al "Sex-related interactive effect of smoking and household pets on asthma incidence." European Respiratory Journal 20.5 (2002): 1162-1166. Web. 23 June. 2021.

L

  1. Larsson, K.

    1. Wadbo, M. et al "Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study." European Respiratory Journal 20.5 (2002): 1138-1146. Web. 23 June. 2021.

  2. Lecarpentier, Y.

    1. Chemla, D. et al "Haemodynamic evaluation of pulmonary hypertension." European Respiratory Journal 20.5 (2002): 1314-1331. Web. 23 June. 2021.

  3. Letourneux, M.

    1. Paris, C. et al "Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure." European Respiratory Journal 20.5 (2002): 1167-1173. Web. 23 June. 2021.

  4. Löfdahl, C-G.

    1. Wadbo, M. et al "Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study." European Respiratory Journal 20.5 (2002): 1138-1146. Web. 23 June. 2021.

  5. Lok, S.S.

    1. Lok, S.S. et al "Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice." European Respiratory Journal 20.5 (2002): 1228-1232. Web. 23 June. 2021.

  6. López-Cozar Gil, A.I.

    1. Ignacio-García, J-M. et al "Benefits at 3 yrs of an asthma education programme coupled with regular reinforcement." European Respiratory Journal 20.5 (2002): 1095-1101. Web. 23 June. 2021.

  7. Losi, M.

    1. Amicosante, M. et al "HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells." European Respiratory Journal 20.5 (2002): 1174-1178. Web. 23 June. 2021.

M

  1. Mackarel, A.J.

    1. Henry, M.T. et al "Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF." European Respiratory Journal 20.5 (2002): 1220-1227. Web. 23 June. 2021.

  2. Magnussen, H.

    1. Kanniess, F. et al "Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma." European Respiratory Journal 20.5 (2002): 1080-1087. Web. 23 June. 2021.

  3. Maisi, P.

    1. Henry, M.T. et al "Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF." European Respiratory Journal 20.5 (2002): 1220-1227. Web. 23 June. 2021.

  4. Marchac, V.

    1. de Blic, J., V. Marchac, and P. Scheinmann. "Complications of flexible bronchoscopy in children: prospective study of 1,328 procedures." European Respiratory Journal 20.5 (2002): 1271-1276. Web. 23 June. 2021.

  5. Martínez, J.A.

    1. Ewig, S. et al "Factors associated with unknown aetiology in patients with community-acquired pneumonia." European Respiratory Journal 20.5 (2002): 1254-1262. Web. 23 June. 2021.

  6. Mason, R.J.

    1. Fehrenbach, H. et al "Keratinocyte growth factor-induced proliferation of rat airway epithelium is restricted to Clara cells in vivo." European Respiratory Journal 20.5 (2002): 1185-1197. Web. 23 June. 2021.

  7. Matthay, M.A.

    1. Sartori, C., and M.A. Matthay. "Alveolar epithelial fluid transport in acute lung injury: new insights." European Respiratory Journal 20.5 (2002): 1299-1313. Web. 23 June. 2021.

  8. McGrath, D.S.

    1. Pantelidis, P. et al "Single-cell analysis: a novel approach to tumour necrosis factor-α synthesis and secretion in sarcoidosis." European Respiratory Journal 20.5 (2002): 1179-1184. Web. 23 June. 2021.

  9. McMahon, K.

    1. Henry, M.T. et al "Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF." European Respiratory Journal 20.5 (2002): 1220-1227. Web. 23 June. 2021.

  10. Mensa, J.

    1. Ewig, S. et al "Factors associated with unknown aetiology in patients with community-acquired pneumonia." European Respiratory Journal 20.5 (2002): 1254-1262. Web. 23 June. 2021.

  11. Mishima, M.

    1. Oga, T. et al "Health status measured with the CRQ does not predict mortality in COPD." European Respiratory Journal 20.5 (2002): 1147-1151. Web. 23 June. 2021.

  12. Morello, R.

    1. Paris, C. et al "Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure." European Respiratory Journal 20.5 (2002): 1167-1173. Web. 23 June. 2021.

  13. Mørkve, O.

    1. Hardie, J.A. et al "Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers." European Respiratory Journal 20.5 (2002): 1117-1122. Web. 23 June. 2021.

N

  1. Nadel, J.A.

    1. Kohri, K. et al "Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor." European Respiratory Journal 20.5 (2002): 1263-1270. Web. 23 June. 2021.

  2. Nakano, H.

    1. Yamamoto, Y. et al "Extrinsic allergic alveolitis induced by the yeast Debaryomyces Hansenii." European Respiratory Journal 20.5 (2002): 1351-1353. Web. 23 June. 2021.

  3. Neumann, M.

    1. Griese, M. et al "Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates." European Respiratory Journal 20.5 (2002): 1284-1291. Web. 23 June. 2021.

  4. Nève, V.

    1. Nève, V. et al "Lung and thorax development during adolescence: relationship with pubertal status." European Respiratory Journal 20.5 (2002): 1292-1298. Web. 23 June. 2021.

  5. Ninomiya, K.

    1. Watanabe, K. et al "Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia." European Respiratory Journal 20.5 (2002): 1213-1219. Web. 23 June. 2021.

  6. Nishimura, K.

    1. Oga, T. et al "Health status measured with the CRQ does not predict mortality in COPD." European Respiratory Journal 20.5 (2002): 1147-1151. Web. 23 June. 2021.

  7. Nørregaard, O.

    1. Nørregaard, O.. "Noninvasive ventilation in children." European Respiratory Journal 20.5 (2002): 1332-1342. Web. 23 June. 2021.

O

  1. O'Connor, C.M.

    1. Henry, M.T. et al "Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF." European Respiratory Journal 20.5 (2002): 1220-1227. Web. 23 June. 2021.

  2. Oga, T.

    1. Oga, T. et al "Health status measured with the CRQ does not predict mortality in COPD." European Respiratory Journal 20.5 (2002): 1147-1151. Web. 23 June. 2021.

  3. Oh, Y-M.

    1. Kohri, K. et al "Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor." European Respiratory Journal 20.5 (2002): 1263-1270. Web. 23 June. 2021.

  4. Ohsaki, Y.

    1. Yamamoto, Y. et al "Extrinsic allergic alveolitis induced by the yeast Debaryomyces Hansenii." European Respiratory Journal 20.5 (2002): 1351-1353. Web. 23 June. 2021.

  5. Ohshima, T.

    1. Watanabe, K. et al "Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia." European Respiratory Journal 20.5 (2002): 1213-1219. Web. 23 June. 2021.

  6. Olgart Höglund, C.

    1. Olgart Höglund, C. et al "Nerve growth factor levels and localisation in human asthmatic bronchi." European Respiratory Journal 20.5 (2002): 1110-1116. Web. 23 June. 2021.

  7. Osanai, S.

    1. Yamamoto, Y. et al "Extrinsic allergic alveolitis induced by the yeast Debaryomyces Hansenii." European Respiratory Journal 20.5 (2002): 1351-1353. Web. 23 June. 2021.

  8. Oster, J-P.

    1. Olgart Höglund, C. et al "Nerve growth factor levels and localisation in human asthmatic bronchi." European Respiratory Journal 20.5 (2002): 1110-1116. Web. 23 June. 2021.

  9. Ouadrhiri, Y.

    1. Pilette, C. et al "Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9." European Respiratory Journal 20.5 (2002): 1198-1205. Web. 23 June. 2021.

P

  1. Pairon, J.C.

    1. Paris, C. et al "Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure." European Respiratory Journal 20.5 (2002): 1167-1173. Web. 23 June. 2021.

  2. Pan, T.

    1. Fehrenbach, H. et al "Keratinocyte growth factor-induced proliferation of rat airway epithelium is restricted to Clara cells in vivo." European Respiratory Journal 20.5 (2002): 1185-1197. Web. 23 June. 2021.

  3. Panoutsopoulos, G.

    1. Alchanatis, M. et al "Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome." European Respiratory Journal 20.5 (2002): 1239-1245. Web. 23 June. 2021.

  4. Pantelidis, P.

    1. Pantelidis, P. et al "Single-cell analysis: a novel approach to tumour necrosis factor-α synthesis and secretion in sarcoidosis." European Respiratory Journal 20.5 (2002): 1179-1184. Web. 23 June. 2021.

  5. Papadima, K.

    1. Alchanatis, M. et al "Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome." European Respiratory Journal 20.5 (2002): 1239-1245. Web. 23 June. 2021.

  6. Paris, C.

    1. Paris, C. et al "Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure." European Respiratory Journal 20.5 (2002): 1167-1173. Web. 23 June. 2021.

  7. Pauli, G.

    1. Olgart Höglund, C. et al "Nerve growth factor levels and localisation in human asthmatic bronchi." European Respiratory Journal 20.5 (2002): 1110-1116. Web. 23 June. 2021.

  8. Petrek, M.

    1. Petrek, M. et al "CC and C chemokine expression in pulmonary sarcoidosis." European Respiratory Journal 20.5 (2002): 1206-1212. Web. 23 June. 2021.

  9. Pilette, C.

    1. Pilette, C. et al "Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9." European Respiratory Journal 20.5 (2002): 1198-1205. Web. 23 June. 2021.

  10. Pinto-Tenorio, M.

    1. Ignacio-García, J-M. et al "Benefits at 3 yrs of an asthma education programme coupled with regular reinforcement." European Respiratory Journal 20.5 (2002): 1095-1101. Web. 23 June. 2021.

  11. Prefaut, C.

    1. Couillard, A. et al "Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients." European Respiratory Journal 20.5 (2002): 1123-1129. Web. 23 June. 2021.

  12. Prikk, K.

    1. Henry, M.T. et al "Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF." European Respiratory Journal 20.5 (2002): 1220-1227. Web. 23 June. 2021.

R

  1. Raffaelli, C.

    1. Paris, C. et al "Asbestos bodies in the sputum of asbestos workers: correlation with occupational exposure." European Respiratory Journal 20.5 (2002): 1167-1173. Web. 23 June. 2021.

  2. Rañó, A.

    1. Ewig, S. et al "Factors associated with unknown aetiology in patients with community-acquired pneumonia." European Respiratory Journal 20.5 (2002): 1254-1262. Web. 23 June. 2021.

  3. Ratjen, F.

    1. Griese, M. et al "Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates." European Respiratory Journal 20.5 (2002): 1284-1291. Web. 23 June. 2021.

  4. Reiss, T.F.

    1. Zhang, J. et al "Variability and lack of predictive ability of asthma end-points in clinical trials." European Respiratory Journal 20.5 (2002): 1102-1109. Web. 23 June. 2021.

  5. Renauld, J-C.

    1. Pilette, C. et al "Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9." European Respiratory Journal 20.5 (2002): 1198-1205. Web. 23 June. 2021.

  6. Richter, K.

    1. Kanniess, F. et al "Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma." European Respiratory Journal 20.5 (2002): 1080-1087. Web. 23 June. 2021.

  7. Robin, M.

    1. Robin, M. et al "Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects." European Respiratory Journal 20.5 (2002): 1152-1161. Web. 23 June. 2021.

  8. Rogliani, P.

    1. Amicosante, M. et al "HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells." European Respiratory Journal 20.5 (2002): 1174-1178. Web. 23 June. 2021.

S

  1. Saltini, C.

    1. Amicosante, M. et al "HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells." European Respiratory Journal 20.5 (2002): 1174-1178. Web. 23 June. 2021.

  2. Sartori, C.

    1. Sartori, C., and M.A. Matthay. "Alveolar epithelial fluid transport in acute lung injury: new insights." European Respiratory Journal 20.5 (2002): 1299-1313. Web. 23 June. 2021.

  3. Sato, S.

    1. Oga, T. et al "Health status measured with the CRQ does not predict mortality in COPD." European Respiratory Journal 20.5 (2002): 1147-1151. Web. 23 June. 2021.

  4. Schauer, U.

    1. Schauer, U. et al "RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life." European Respiratory Journal 20.5 (2002): 1277-1283. Web. 23 June. 2021.

  5. Scheinmann, P.

    1. de Blic, J., V. Marchac, and P. Scheinmann. "Complications of flexible bronchoscopy in children: prospective study of 1,328 procedures." European Respiratory Journal 20.5 (2002): 1271-1276. Web. 23 June. 2021.

  6. Schleiss, M.B.

    1. Kanniess, F. et al "Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma." European Respiratory Journal 20.5 (2002): 1080-1087. Web. 23 June. 2021.

  7. Schmidt, R.

    1. Griese, M. et al "Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates." European Respiratory Journal 20.5 (2002): 1284-1291. Web. 23 June. 2021.

  8. Sepper, R.

    1. Henry, M.T. et al "Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF." European Respiratory Journal 20.5 (2002): 1220-1227. Web. 23 June. 2021.

  9. Shim, J-J.

    1. Kohri, K. et al "Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor." European Respiratory Journal 20.5 (2002): 1263-1270. Web. 23 June. 2021.

  10. Sibille, Y.

    1. Pilette, C. et al "Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9." European Respiratory Journal 20.5 (2002): 1198-1205. Web. 23 June. 2021.

  11. Skoogh, B.E.

    1. Wadbo, M. et al "Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study." European Respiratory Journal 20.5 (2002): 1138-1146. Web. 23 June. 2021.

  12. Solèr, M.

    1. Buhl, R. et al "The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma." European Respiratory Journal 20.5 (2002): 1088-1094. Web. 23 June. 2021.

  13. Sorsa, T.

    1. Henry, M.T. et al "Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF." European Respiratory Journal 20.5 (2002): 1220-1227. Web. 23 June. 2021.

  14. Southcott, A.M.

    1. Pantelidis, P. et al "Single-cell analysis: a novel approach to tumour necrosis factor-α synthesis and secretion in sarcoidosis." European Respiratory Journal 20.5 (2002): 1179-1184. Web. 23 June. 2021.

  15. Spengler, J.D.

    1. Horak, F. et al "From the Authors." European Respiratory Journal 20.5 (2002): 1355. Web. 23 June. 2021.

  16. Staquet, P.

    1. Pilette, C. et al "Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9." European Respiratory Journal 20.5 (2002): 1198-1205. Web. 23 June. 2021.

  17. Stephan, V.

    1. Schauer, U. et al "RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life." European Respiratory Journal 20.5 (2002): 1277-1283. Web. 23 June. 2021.

  18. Stewart, J.P.

    1. Lok, S.S. et al "Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice." European Respiratory Journal 20.5 (2002): 1228-1232. Web. 23 June. 2021.

  19. Ström, K.

    1. Wadbo, M. et al "Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study." European Respiratory Journal 20.5 (2002): 1138-1146. Web. 23 June. 2021.

  20. Studnicka, M.

    1. Horak, F. et al "From the Authors." European Respiratory Journal 20.5 (2002): 1355. Web. 23 June. 2021.

  21. Szczepura, A.

    1. Chakravorty, I., R.M. Cayton, and A. Szczepura. "Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome." European Respiratory Journal 20.5 (2002): 1233-1238. Web. 23 June. 2021.

  22. Szotkowská, J.

    1. Petrek, M. et al "CC and C chemokine expression in pulmonary sarcoidosis." European Respiratory Journal 20.5 (2002): 1206-1212. Web. 23 June. 2021.

T

  1. Tam, D.C.

    1. Kohri, K. et al "Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor." European Respiratory Journal 20.5 (2002): 1263-1270. Web. 23 June. 2021.

  2. Tang, M.

    1. Chen, Y. et al "Sex-related interactive effect of smoking and household pets on asthma incidence." European Respiratory Journal 20.5 (2002): 1162-1166. Web. 23 June. 2021.

  3. Tauber, E.

    1. Horak, F. et al "From the Authors." European Respiratory Journal 20.5 (2002): 1355. Web. 23 June. 2021.

  4. Teppema, L.J.

    1. Wagenaar, M. et al "Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients." European Respiratory Journal 20.5 (2002): 1130-1137. Web. 23 June. 2021.

  5. Thirlwell, J.

    1. Buhl, R. et al "The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma." European Respiratory Journal 20.5 (2002): 1088-1094. Web. 23 June. 2021.

  6. Tornling, G.

    1. Wadbo, M. et al "Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study." European Respiratory Journal 20.5 (2002): 1138-1146. Web. 23 June. 2021.

  7. Torres, A.

    1. Ewig, S. et al "Factors associated with unknown aetiology in patients with community-acquired pneumonia." European Respiratory Journal 20.5 (2002): 1254-1262. Web. 23 June. 2021.

  8. Tourkohoriti, G.

    1. Alchanatis, M. et al "Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome." European Respiratory Journal 20.5 (2002): 1239-1245. Web. 23 June. 2021.

  9. Tsukino, M.

    1. Oga, T. et al "Health status measured with the CRQ does not predict mortality in COPD." European Respiratory Journal 20.5 (2002): 1147-1151. Web. 23 June. 2021.

U

  1. Ueki, I.F.

    1. Kohri, K. et al "Pseudomonas aeruginosa induces MUC5AC production via epidermal growth factor receptor." European Respiratory Journal 20.5 (2002): 1263-1270. Web. 23 June. 2021.

  2. Urbanek, R.

    1. Horak, F. et al "From the Authors." European Respiratory Journal 20.5 (2002): 1355. Web. 23 June. 2021.

V

  1. Vaerman, J-P.

    1. Pilette, C. et al "Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9." European Respiratory Journal 20.5 (2002): 1198-1205. Web. 23 June. 2021.

  2. Van Snick, J.

    1. Pilette, C. et al "Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9." European Respiratory Journal 20.5 (2002): 1198-1205. Web. 23 June. 2021.

  3. Varray, A.

    1. Couillard, A. et al "Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients." European Respiratory Journal 20.5 (2002): 1123-1129. Web. 23 June. 2021.

  4. Veiter, A.

    1. Horak, F. et al "From the Authors." European Respiratory Journal 20.5 (2002): 1355. Web. 23 June. 2021.

  5. Vollmer, W.M.

    1. Hardie, J.A. et al "Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers." European Respiratory Journal 20.5 (2002): 1117-1122. Web. 23 June. 2021.

  6. von Bredow, T.

    1. Griese, M. et al "Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates." European Respiratory Journal 20.5 (2002): 1284-1291. Web. 23 June. 2021.

W

  1. Wadbo, M.

    1. Wadbo, M. et al "Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study." European Respiratory Journal 20.5 (2002): 1138-1146. Web. 23 June. 2021.

  2. Wagenaar, M.

    1. Wagenaar, M. et al "Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients." European Respiratory Journal 20.5 (2002): 1130-1137. Web. 23 June. 2021.

  3. Watanabe, K.

    1. Watanabe, K. et al "Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia." European Respiratory Journal 20.5 (2002): 1213-1219. Web. 23 June. 2021.

  4. Witt, C.

    1. Dingli, K. et al "Electroencephalographic spectral analysis: detection of cortical activity changes in sleep apnoea patients." European Respiratory Journal 20.5 (2002): 1246-1253. Web. 23 June. 2021.

  5. Wolfe, J.

    1. Buhl, R. et al "The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma." European Respiratory Journal 20.5 (2002): 1088-1094. Web. 23 June. 2021.

  6. Wraith, P.K.

    1. Dingli, K. et al "Electroencephalographic spectral analysis: detection of cortical activity changes in sleep apnoea patients." European Respiratory Journal 20.5 (2002): 1246-1253. Web. 23 June. 2021.

Y

  1. Yamamoto, Y.

    1. Yamamoto, Y. et al "Extrinsic allergic alveolitis induced by the yeast Debaryomyces Hansenii." European Respiratory Journal 20.5 (2002): 1351-1353. Web. 23 June. 2021.

  2. Yamazaki, K.

    1. Yamamoto, Y. et al "Extrinsic allergic alveolitis induced by the yeast Debaryomyces Hansenii." European Respiratory Journal 20.5 (2002): 1351-1353. Web. 23 June. 2021.

  3. Yoshida, M.

    1. Watanabe, K. et al "Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia." European Respiratory Journal 20.5 (2002): 1213-1219. Web. 23 June. 2021.

  4. Yu, C.

    1. Zhang, J. et al "Variability and lack of predictive ability of asthma end-points in clinical trials." European Respiratory Journal 20.5 (2002): 1102-1109. Web. 23 June. 2021.

Z

  1. Zhang, J.

    1. Zhang, J. et al "Variability and lack of predictive ability of asthma end-points in clinical trials." European Respiratory Journal 20.5 (2002): 1102-1109. Web. 23 June. 2021.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts